Meanwhile, some study have experimentally confirmed that the SGK2 regulates the degradation of oncogenic protein PTOV1 [54]; serves as a synthetic lethality target in p53−/− cells [55–57]; and promotes cancer cell migration and resistance [58–60]. The gene discussed is TP53; the disease is cancer.